EUVIMEDEUVIMED entdecken
Crossref

Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis

Jessica M Hughes, Joo Y Song, Winston Y Lee, Alexey V Danilov, Matthew G Mei, Huiyan Ma, Parastou Tizro, Olga V Danilova, Lorinda A Soma

Cytometry Part B: Clinical Cytometry · 2025

DOI: 10.1002/cyto.b.22263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2025. Verfasst von Jessica M Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Division of Hematopathology, City of Hope National Medical Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual, Plasma Cells. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measurable residual disease (MRD) testing for chronic lymphocytic leukemia (CLL) is often done on peripheral blood (PB) since the concordance of results with bone marrow is high and testing is less invasive. When analyzing CLL MRD data, one must be aware of small, normal populations in the PB that may be mistaken for residual CLL cells. As part of our CLL MRD assay validation, PB samples were collected from 10 healthy donors and a 2‐tube CLL MRD flow cytometry panel was stained for each donor using markers CD19, CD20, BAFF‐R, kappa, lambda, CD5, CD200, CD23, CD38, CD81, ROR1, CD79b, CD43, and CD45. Additional markers were utilized to exclude T‐cells, NK‐cells, and myeloid cells from the analysis. Samples were acquired on the Navios EX flow cytometer, and the data were analyzed using FCS Express software. Once the test was implemented, CLL PB patient samples were monitored. All 10 PBs from healthy donors contained small populations of cells present in the lymphocyte gate which mimicked CLL cells in their expression of CD45, CD19, CD20, CD43 (both positive, although CLL cells showed dimmer positive expression), CD79b, and level of surface light chains, immunophenotypically compatible with plasmablasts. Clinical implementation of the CLL assay revealed 12 out of 77 (16%) CLL PB patient samples demonstrating a small population of plasmablasts. Plasmablasts normally exist in peripheral blood at levels detectable by flow cytometry MRD assays and may be a potential confounder in the identification of MRD in CLL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellNeoplasm, ResidualPlasma CellsHumansFlow CytometryAntigens, CDImmunophenotypingFemale

Stichwörter der Autor:innen

CLLMRDplasmablasts

Substanzen

Antigens, CD

Autor:innen und Institutionen

  • Department of Pathology, Division of Hematopathology, City of Hope National Medical Center, Duarte, California, USA.
  • Department of Hematology & Hematopoietic Cell Transplantation, Division of Lymphoma, City of Hope National Medical Center, Duarte, California, USA.
  • Department of Computational and Quantitative Medicine, Division of Biostatistics, Beckman Research Institute of City of Hope, Duarte, California, USA.

Zitieren

APA

Hughes, J. M., Song, J. Y., Lee, W. Y., Danilov, A. V., Mei, M. G., Ma, H., Tizro, P., Danilova, O. V., & Soma, L. A. (2025). Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22263

Vancouver

Hughes JM, Song JY, Lee WY, Danilov AV, Mei MG, Ma H, et al. Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis. Cytometry Part B: Clinical Cytometry. 2025. doi:10.1002/cyto.b.22263

BibTeX
@article{Hughes2025,
  author = {Hughes, Jessica M and Song, Joo Y and Lee, Winston Y and Danilov, Alexey V and Mei, Matthew G and Ma, Huiyan and Tizro, Parastou and Danilova, Olga V and Soma, Lorinda A},
  title = {Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2025},
  doi = {10.1002/cyto.b.22263}
}
Kostenlos starten →